内蒙治白癜风全国哪家好内蒙白癜风治疗地方,河北治疗白癜风最好的哪里,浙江白癜风专科大夫,广东哪里治白癜风好呢,天津白癜风发病初期症状,河北白癜风在治疗过程中会,广东白癜风专科治疗

AUSTIN, Texas — For Brett Hagler, the co-founder of non-profit New Story, building homes for people without adequate shelter is nothing new."We get a large piece of land and work with families that have been living in shacks or tents without shelter and design a totally new community with the families.”Approximately one billion of the world’s population is without proper shelter.To make a dent in that he says, they have to think outside the mold.“We believe traditional ways cannot get us there.”So for New Story’s next endeavor—adding more communities to the land they’ve already acquired in El Salvador—they teamed up with a brand new startup.That’s where Evan Loomis comes in. He’s the co-founder of Austin, Texas-based Icon, a company focused on new technologies for building homes.Their first big debut came at this year’s South by Southwest festival in their hometown.“This is a gigantic robot,” Loomis says, gesturing toward a large steel frame on wheels. “[It] really does some amazing things. Down to the millimeter it knows exactly where to place building materials.”In this case that material is a proprietary mixture of concrete, that pours out of a nozzle on the underside of the metalwork. And the machine moves along a computerized map to create a house.“This is basically the first permitted 3D printed house in the United States,” he said.“We have to invest in [research and design],” Hagler said. “[We asked ourselves] ‘how do we get a breakthrough in cost, speed, and quality?’ And that’s how we landed upon 3D-home printing. The excitement in the air is palpable as they walk us through and around this modest home built up of about 100 one-inch thick concrete layers.“It’s stronger than regular cinder block,” Hagler said. It also comes at a fraction of the cost of a regular house. This model had a price tag of about ,000 but they hope to get the price down to ,000.“We can build in a fraction of the time [compared to traditional construction methods], and it can have a higher quality, strength, and sustainability for the environment."It was 'printed' in just 48 hours. Eventually, they say it will be done in just a half day. It’s a small but open floor plan — with no physical doors — and rooms are separated by partial walls made up of the printed concrete.They say they’ll easily be able to customize different designs.The prototype home can fit a family of four or five.“If you’re coming from a tent or shack and you move into this,” Hagler said, “it’s a significant life-changing difference.”One of the things they’re most excited about with their upcoming 3D-homes project in El Salvador is the fact that they’re introducing groundbreaking technology to the people who usually see tech advances last.“We are actually bringing them the future -- which is robotic construction of housing — first,” Hagler said. “And they’re really excited about that.”They say they plan to begin construction in El Salvador before the end of the year with the hopes of finishing their first community of homes by early 2019. There could one day be plans for 3D printed homes in some of the poorest areas of the United States as well, Loomis said, but he has his eye set on possibly expanding to terrain that’s literally out of this world.“It could be a really great solution for making space habitation a lot more achievable,” Loomis said. “We hit a nerve with this technology, and we are going to hit the gas hard and try to take it to everybody now.” 3528

AUSTIN, Texas (AP) — The chairman of a panel considering changes to the U.S. military draft said Monday its recommendations to Congress won't be influenced by a federal judge's recent ruling that the current system is unconstitutional because it only applies to men.The military has not drafted anyone into service in more than 40 years, but American men must still register when they turn 18. Recent efforts to make registration also mandatory for women have set off intense debate in Washington.U.S. District Judge Gray Miller declared a male-only draft unconstitutional in his ruling late Friday, but he stopped of ordering the government to make any immediate changes. He said the time for debating "the place of women in the Armed Forces" is over. Women now make up 20 percent of the Air Force, 19 percent of the Navy, 15 percent of the Army and 8.6 percent of the Marines, according to Pentagon figures.The Justice Department declined comment Monday after losing the case out of Houston.RELATED: Federal judge rules male-only draft is unconstitutionalThe decision comes as Congress awaits a report next year from an 11-member commission to study the issue of selective service. It is chaired by former Nevada Rep. Joe Heck, who personally supports that women also be required to register for the draft.Heck said the ruling won't influence its report or hurry along the eventual recommendations to Congress. He described a generational divide in public comments his commission has collected about women and the draft."If you talk to those who would be impacted, that is males and females ages 18 to 25, they say, 'yes, women should have to register. It's a matter of equality,'" Heck said. "If you talk to an older population, they're the ones who seem to be reluctant."RELATED: Generals push for women draft registrationThe lawsuit in Texas was brought by the National Coalition for Men, a men's rights group. The Defense Department lifted the ban on women in combat in 2013, and Miller stopped of ordering the government to take any immediate action with the draft in his ruling late Friday."I actually thought the judge did that to give them time, because this is such a major change," said Marc Angelucci, a lawyer for the men's group.The last major decision on selective service was the U.S. Supreme Court ruling in 1981 that upheld excluding women because they were not allowed to serve in comment at the time.Miller, who was appointed by former President George W. Bush in 2006, noted that was no longer the case."While historical restrictions on women in the military may have justified past discrimination, men and women are now 'similarly situated for purposes of a draft or registration for a draft,'" Miller wrote. "If there ever was a time to discuss 'the place of women in the Armed Services,' that time has passed." 2843

As scientists learn more about COVID-19, they are realizing that how people react to the virus could be based on the body's response to viruses like common colds.Meharry Medical College President Dr. James Hildreth says some studies are showing some individuals have T-cell responses to COVID-19 even though they never been exposed to it.He is talking about recent research revealing that some people may have immunity defenders called T-cells which could determine how their body reacts to COVID-19.According to the CDC, when the body fights an infection, the immune system remembers what it learned about how to protect the body against that disease.The body will retain a few specific T-cells known as memory cells - that will alert and help the immune system identify and produce antibodies to attack the foreign germ if it enters the body again."Viruses that look alike can sometimes elicit the same kinds of immune responses," said Hildreth.Hildreth says there are six strains of coronavirus that affect humans going back to the 1960s and some result in seasonal common colds.He says if you were infected with one of these viruses in the past it can determine the severity of the toll COVID-19 would take on your body now."There’s the possibility that a response to one of them gives you a partial to another because they have genetic similarities," said Hildreth.Hildreth says this doesn't mean a person has complete immunity to COVID-19."There’s strong evidence that you may not be immune to the virus, but you’ll have an immune response that recognizes SARS partially just because those two viruses look so much alike."Hildreth says this can help with treatments and even vaccinesThis story was originally reported by Kelsey Gibbs at WTVF. 1756

As the chaotic 2020 presidential race enters its final stretch, Vice President Mike Pence and Democratic vice presidential nominee Kamala Harris will square off in a debate at 9 p.m. ET on Wednesday in Salt Lake City.The COVID-19 pandemic will be at the forefront of Wednesday's debate — both literally and figuratively. As the nation seeks more info regarding President Donald Trump's health amid his COVID-19 infection, both Pence and Harris have agreed to allow debate officials to install plexiglass shields next to their podiums.Harris' staff initially requested the shields, citing the COVID-19 outbreak that's infected several White House staffers. After initially saying the shields were not necessary, Pence's staff agreed to the change on Tuesday night.The Associated Press reports that both Harris and Pence tested negative for the virus on Tuesday morning.Wednesday's debate will be broken into nine 10-minute segments. Each candidate will have two minutes to answer a question from moderator Susan Page, and the other candidate will then have two minutes to respond.The 2020 VP debate will likely hold more important than in years past, given the ages of Trump and his opponent, former Vice President Joe Biden. Trump, 74, was the oldest candidate ever to be elected president in 2016, and Biden, 77, is three years older than Trump. Amid a global pandemic, voters may be taking a keen interest in each administration's chain of command.The Trump campaign is banking on a strong performance from Pence amid slumping poll numbers. An average of national polls shows Biden leading Trump by about nine percentage points, and a recent CNN poll released this week showed that 57% of likely voters favored Biden, compared to just 41% for Trump.Wednesday may also mark the last debate for at least a few weeks. There are two more presidential debates scheduled between now and Nov. 3, but Trump's COVID-19 diagnosis has put the status of the second debate — currently scheduled for a week from Thursday — in doubt. Trump says he still plans to participate, but Biden has said the debate should not take place if the president is still infected with the virus due to safety concerns. 2196

AstraZeneca is the latest drugmaker to announce promising Phase 3 trial results from its COVID-19 vaccine candidate.On Monday, AstraZeneca said its two-shot vaccine candidate has been 90% effective thus far along with no safety concerns.“These findings show that we have an effective vaccine that will save many lives," said Professor Andrew Pollard, the chief executive of the study. Excitingly, we’ve found that one of our dosing regimens may be around 90% effective and if this dosing regime is used, more people could be vaccinated with planned vaccine supply. Today’s announcement is only possible thanks to the many volunteers in our trial, and the hard working and talented team of researchers based around the world.”The company added in its press release that its vaccine candidate offers two distinct advantages over vaccines made by Pfizer and Moderna — it's cheaper to produce, and does not need to be stored in ultra-cold conditions before use.AstraZeneca added that the company would "immediately" prepare regulatory paperwork to seek Emergency Use Listing status from the World Health Organization.AstraZeneca is just the latest drug company to report encouraging results from its COVID-19 vaccine candidate.Last week, Pfizer said it had submitted Emergency Use Authorization paperwork to the Food & Drug Administration (FDA) after a final analysis of its vaccine candidate proved to be 95% effective in preventing COVID-19. The FDA is expected to approve the drug in the coming weeks.Moderna has also said that early results show its vaccine candidate to be 95% effective, and is on track to have the drug approved for Emergency Use Authorization by the end of the year.AstraZeneca, Pfizer and Moderna are all shattering records for vaccine development. The three vaccines are all on track to be approved for widespread use in uder a year. Typically, it takes several years for a vaccine to go from development to approval.The announcement comes as COVID-19 is spreading around the world at a rate not previously seen since the pandemic began. And while all three companies are pre-producing their vaccines in the hope that it will be approved, health experts warn that they won't be widely available until spring 2021. 2247